- Home
- BANR vs HCM Comparison
BANR vs HCM Comparison
Compare BANR & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANR
- HCM
- Stock Information
- Founded
- BANR 1890
- HCM 2000
- Country
- BANR United States
- HCM Hong Kong
- Employees
- BANR N/A
- HCM N/A
- Industry
- BANR Major Banks
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- BANR Finance
- HCM Health Care
- Exchange
- BANR Nasdaq
- HCM Nasdaq
- Market Cap
- BANR 2.3B
- HCM 2.6B
- IPO Year
- BANR 1995
- HCM N/A
- Fundamental
- Price
- BANR $63.81
- HCM $15.25
- Analyst Decision
- BANR Buy
- HCM Hold
- Analyst Count
- BANR 6
- HCM 1
- Target Price
- BANR $73.80
- HCM $19.00
- AVG Volume (30 Days)
- BANR 256.2K
- HCM 85.0K
- Earning Date
- BANR 04-16-2025
- HCM 03-19-2025
- Dividend Yield
- BANR 3.01%
- HCM N/A
- EPS Growth
- BANR N/A
- HCM N/A
- EPS
- BANR 4.88
- HCM 0.04
- Revenue
- BANR $601,023,000.00
- HCM $630,201,000.00
- Revenue This Year
- BANR $1.10
- HCM $28.98
- Revenue Next Year
- BANR $6.35
- HCM $20.41
- P/E Ratio
- BANR $13.08
- HCM $69.52
- Revenue Growth
- BANR N/A
- HCM N/A
- 52 Week Low
- BANR $42.00
- HCM $12.84
- 52 Week High
- BANR $78.05
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- BANR 42.04
- HCM 50.03
- Support Level
- BANR $63.23
- HCM $14.00
- Resistance Level
- BANR $66.55
- HCM $16.64
- Average True Range (ATR)
- BANR 1.83
- HCM 0.47
- MACD
- BANR 0.19
- HCM -0.12
- Stochastic Oscillator
- BANR 29.23
- HCM 47.35
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.